Evoke Pharma Inc (EVOK)
5.46
-0.26
(-4.55%)
USD |
NASDAQ |
Nov 05, 11:19
Evoke Pharma Price: 5.46 for Nov. 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 5.70 | 6.00 | 5.304 | 5.72 | 64221.00 |
| Nov 01, 2024 | 5.97 | 6.200 | 5.80 | 5.80 | 91013.00 |
| Oct 31, 2024 | 6.58 | 6.58 | 5.66 | 5.85 | 146528.0 |
| Oct 30, 2024 | 6.19 | 6.71 | 6.08 | 6.45 | 225926.0 |
| Oct 29, 2024 | 6.43 | 6.685 | 5.72 | 6.30 | 587761.0 |
| Oct 28, 2024 | 11.11 | 12.32 | 6.83 | 7.08 | 21.13M |
| Oct 25, 2024 | 5.070 | 5.30 | 4.81 | 5.30 | 13825.00 |
| Oct 24, 2024 | 5.15 | 5.61 | 5.13 | 5.13 | 3917.00 |
| Oct 23, 2024 | 5.205 | 5.40 | 5.01 | 5.13 | 11630.00 |
| Oct 22, 2024 | 5.545 | 5.565 | 5.40 | 5.40 | 14452.00 |
| Oct 21, 2024 | 5.61 | 5.61 | 5.45 | 5.48 | 6852.00 |
| Oct 18, 2024 | 5.39 | 5.54 | 5.14 | 5.51 | 15621.00 |
| Oct 17, 2024 | 5.162 | 5.383 | 5.162 | 5.336 | 1310.00 |
| Oct 16, 2024 | 5.30 | 5.43 | 5.12 | 5.14 | 10805.00 |
| Oct 15, 2024 | 5.30 | 5.357 | 5.10 | 5.11 | 6142.00 |
| Oct 14, 2024 | 5.28 | 5.502 | 4.81 | 5.090 | 14055.00 |
| Oct 11, 2024 | 5.331 | 5.75 | 5.19 | 5.19 | 12128.00 |
| Oct 10, 2024 | 5.325 | 5.426 | 5.19 | 5.32 | 1815.00 |
| Oct 09, 2024 | 5.428 | 5.567 | 5.08 | 5.17 | 15242.00 |
| Oct 08, 2024 | 5.37 | 5.754 | 5.25 | 5.57 | 8181.00 |
| Oct 07, 2024 | 5.35 | 5.66 | 5.11 | 5.38 | 25976.00 |
| Oct 04, 2024 | 5.05 | 6.00 | 4.91 | 5.25 | 218578.0 |
| Oct 03, 2024 | 4.95 | 5.25 | 4.915 | 5.20 | 29679.00 |
| Oct 02, 2024 | 5.19 | 5.19 | 4.734 | 4.95 | 38478.00 |
| Oct 01, 2024 | 4.90 | 4.90 | 4.510 | 4.870 | 17186.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.87
Minimum
Sep 06 2024
820.80
Maximum
Aug 14 2020
148.81
Average
56.19
Median
Apr 11 2022
Price Benchmarks
| Repligen Corp | 141.93 |
| NovaBay Pharmaceuticals Inc | 0.77 |
| Palatin Technologies Inc | 1.21 |
| iBio Inc | 2.705 |
| Theriva Biologics Inc | 2.00 |
Price Related Metrics
| PS Ratio | 0.2590 |
| Price to Book Value | 1.506 |
| Earnings Yield | -483.5% |
| Market Cap | 4.012M |